ARTICLE | Company News
Oxford GlycoSciences gets EU Orphan designation
October 25, 2000 7:00 AM UTC
Oxford GlycoSciences (LSE:OGS) received European Orphan Medicinal Product designation for Vevesca ( OGT 918), an inhibitor of the glucosyltransferase enzyme in Phase I/II testing to treat Gaucher dise...